In the case of EBV + B-lymphoma, these cells are clonotypic clonogenic cells, which express the CD133 marker of cancer stem cells and are crucial for the development of subcutaneous grafts (Dolgova et al., 2016b, 2019). The gene discussed is PROM1; the disease is cancer.